{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:29:36Z","timestamp":1788870576127,"version":"build-2803163510"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T00:00:00Z","timestamp":1329868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG STE1051\/2-1"],"award-info":[{"award-number":["DFG STE1051\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002745","name":"Bayerische Forschungsstiftung","doi-asserted-by":"publisher","award":["FORZEBRA TP2-WP5"],"award-info":[{"award-number":["FORZEBRA TP2-WP5"]}],"id":[{"id":"10.13039\/501100002745","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung W\u00fcrzburg","award":["IZKF D-101"],"award-info":[{"award-number":["IZKF D-101"]}]},{"name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung W\u00fcrzburg","award":["D-219"],"award-info":[{"award-number":["D-219"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Regenerative therapies in the musculoskeletal system are based on the suitable application of cells, biomaterials, and\/or factors. For an effective approach, numerous aspects have to be taken into consideration, including age, disease, target tissue, and several environmental factors. Significant research efforts have been undertaken in the last decade to develop specific cell-based therapies, and in particular adult multipotent mesenchymal stem cells hold great promise for such regenerative strategies. Clinical translation of such therapies, however, remains a work in progress. In the clinical arena, autologous cells have been harvested, processed, and readministered according to protocols distinct for the target application. As outlined in this review, such applications range from simple single-step approaches, such as direct injection of unprocessed or concentrated blood or bone marrow aspirates, to fabrication of engineered constructs by seeding of natural or synthetic scaffolds with cells, which were released from autologous tissues and propagated under good manufacturing practice conditions (for example, autologous chondrocyte implantation). However, only relatively few of these cell-based approaches have entered the clinic, and none of these treatments has become a \u201cstandard of care\u201d treatment for an orthopaedic disease to date. The multifaceted reasons for the current status from the medical, research, and regulatory perspectives are discussed here. In summary, this review presents the scientific background, current state, and implications of clinical mesenchymal stem cell application in the musculoskeletal system and provides perspectives for future developments.<\/jats:p>","DOI":"10.5966\/sctm.2011-0036","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T11:27:30Z","timestamp":1336735650000},"page":"237-247","source":"Crossref","is-referenced-by-count":196,"title":["Concise Review: The Clinical Application of Mesenchymal Stem Cells for Musculoskeletal Regeneration: Current Status and Perspectives"],"prefix":"10.1093","volume":"1","author":[{"given":"Andre F.","family":"Steinert","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, K\u00f6nig-Ludwig-Haus, Orthopaedic Center for Musculoskeletal Research, Julius-Maximilians-University, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rackwitz","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, K\u00f6nig-Ludwig-Haus, Orthopaedic Center for Musculoskeletal Research, Julius-Maximilians-University, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, K\u00f6nig-Ludwig-Haus, Orthopaedic Center for Musculoskeletal Research, Julius-Maximilians-University, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"N\u00f6th","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, K\u00f6nig-Ludwig-Haus, Orthopaedic Center for Musculoskeletal Research, Julius-Maximilians-University, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocky S.","family":"Tuan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Center for Cellular and Molecular Engineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"2021122217020526900_ref1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.addr.2010.04.004","article-title":"Cell delivery therapeutics for musculoskeletal regeneration","volume":"62","author":"N\u00f6th","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"2021122217020526900_ref2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jcp.21940","article-title":"Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis","volume":"222","author":"Kuhn","year":"2010","journal-title":"J Cell Physiol"},{"key":"2021122217020526900_ref3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/stem.603","article-title":"Concise review: Culture mediated changes in fate and\/or potency of stem cells","volume":"29","author":"Roobrouck","year":"2011","journal-title":"Stem Cells"},{"key":"2021122217020526900_ref4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/term.234","article-title":"Skeletal tissue engineering using embryonic stem cells","volume":"4","author":"Jukes","year":"2010","journal-title":"J Tissue Eng Regen Med"},{"key":"2021122217020526900_ref5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2021122217020526900_ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2021122217020526900_ref7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nbt1335","article-title":"Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells","volume":"25","author":"Meissner","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2021122217020526900_ref8","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"2021122217020526900_ref9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/stem.611","article-title":"Concise review: Induced pluripotent stem cells and lineage reprogramming: Prospects for bone regeneration","volume":"29","author":"Illich","year":"2011","journal-title":"Stem Cells"},{"key":"2021122217020526900_ref10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2021122217020526900_ref11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"2021122217020526900_ref12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1089\/ten.2005.11.1198","article-title":"Review: Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics","volume":"11","author":"Caplan","year":"2005","journal-title":"Tissue Eng"},{"key":"2021122217020526900_ref13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/bdrc.20174","article-title":"Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells","volume":"90","author":"Petrie Aronin","year":"2010","journal-title":"Birth Defects Res C Embryo Today"},{"key":"2021122217020526900_ref14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar2116","article-title":"Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation","volume":"9","author":"Kolf","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2021122217020526900_ref15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ncprheum0816","article-title":"Technology insight: Adult mesenchymal stem cells for osteoarthritis therapy","volume":"4","author":"N\u00f6th","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2021122217020526900_ref16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5435\/00124635-201103000-00002","article-title":"Tissue engineering solutions for tendon repair","volume":"19","author":"Hogan","year":"2011","journal-title":"J Am Acad Orthop Surg"},{"key":"2021122217020526900_ref17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1089\/ten.2006.0271","article-title":"Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study","volume":"13","author":"Marcacci","year":"2007","journal-title":"Tissue Eng"},{"issue":"suppl 1","key":"2021122217020526900_ref18","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.injury.2008.01.040","article-title":"Autologous chondrocyte implantation\u2014technique and long-term follow-up","volume":"39","author":"Brittberg","year":"2008","journal-title":"Injury"},{"key":"2021122217020526900_ref19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00132-007-1087-2","article-title":"Cell based therapy for the treatment of femoral head necrosis","volume":"36","author":"N\u00f6th","year":"2007","journal-title":"Orthopade"},{"key":"2021122217020526900_ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jor.20305","article-title":"Nanobiomaterial applications in orthopedics","volume":"25","author":"Christenson","year":"2007","journal-title":"J Orthop Res"},{"key":"2021122217020526900_ref21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.addr.2007.08.041","article-title":"Biomimetic materials for tissue engineering","volume":"60","author":"Ma","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"2021122217020526900_ref22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.abb.2008.03.024","article-title":"Bridging the regeneration gap: Stem cells, biomaterials and clinical translation in bone tissue engineering","volume":"473","author":"Dawson","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"suppl 1","key":"2021122217020526900_ref23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2106\/JBJS.G.01260","article-title":"Tissue engineering of bone: Material and matrix considerations","volume":"90","author":"Khan","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1098\/rsif.2007.0220","article-title":"Natural origin biodegradable systems in tissue engineering and regenerative medicine: Present status and some moving trends","volume":"4","author":"Mano","year":"2007","journal-title":"J R Soc Interface"},{"key":"2021122217020526900_ref25","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.biomaterials.2006.01.039","article-title":"Biodegradable and bioactive porous polymer\/inorganic composite scaffolds for bone tissue engineering","volume":"27","author":"Rezwan","year":"2006","journal-title":"Biomaterials"},{"key":"2021122217020526900_ref26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.bor.0000198005.88568.df","article-title":"Cartilage tissue engineering: Its potential and uses","volume":"18","author":"Kuo","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"2021122217020526900_ref27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ncprheum0216","article-title":"Technology insight: Adult stem cells in cartilage regeneration and tissue engineering","volume":"2","author":"Chen","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2021122217020526900_ref28","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb2502s42","article-title":"Fabrication and application of nanofibrous scaffolds in tissue engineering","author":"Li","year":"2009","journal-title":"Curr Protoc Cell Biol"},{"key":"2021122217020526900_ref29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar2195","article-title":"Major biological obstacles for persistent cell-based regeneration of articular cartilage","volume":"9","author":"Steinert","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2021122217020526900_ref30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.coi.2011.05.007","article-title":"Inflammation and mesenchymal stem cell aging","volume":"23","author":"Lepperdinger","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"suppl","key":"2021122217020526900_ref31","first-page":"50","article-title":"Role of adult stem\/progenitor cells in osseointegration and implant loosening","volume":"26","author":"Tuan","year":"2011","journal-title":"Int J Oral Maxillofac Implants"},{"key":"2021122217020526900_ref32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/ten.teb.2010.0612","article-title":"Bioreactor systems for bone tissue engineering","volume":"17","author":"Rauh","year":"2011","journal-title":"Tissue Eng Part B Rev"},{"key":"2021122217020526900_ref33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.injury.2011.03.030","article-title":"Mesenchymal stem cells and bone regeneration: Current status","volume":"42","author":"Jones","year":"2011","journal-title":"Injury"},{"key":"2021122217020526900_ref34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1634\/stemcells.21-5-610","article-title":"Cell therapy for bone disease: A review of current status","volume":"21","author":"Cancedda","year":"2003","journal-title":"Stem Cells"},{"key":"2021122217020526900_ref35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/bmb\/ldr035","article-title":"Stem cells in bone diseases: Current clinical practice","volume":"99","author":"Beyth","year":"2011","journal-title":"Br Med Bull"},{"issue":"suppl","key":"2021122217020526900_ref36","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1097\/00003086-199810001-00026","article-title":"Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis","volume":"355","author":"Connolly","year":"1998","journal-title":"Clin Orthop Relat Res"},{"key":"2021122217020526900_ref37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00003086-200212000-00003","article-title":"Treatment of osteonecrosis with autologous bone marrow grafting","volume":"405","author":"Hernigou","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"2021122217020526900_ref38","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2106\/00004623-200711000-00011","article-title":"Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells","volume":"89","author":"Dallari","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2007-965204","article-title":"A novel therapeutic approach to bone replacement: Vitalisation of industrial processed allogenic bone graft with autologous bone marrow","volume":"145","author":"Schmid","year":"2007","journal-title":"Z Orthop Unfall"},{"key":"2021122217020526900_ref40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(04)16935-3","article-title":"Growth and transplantation of a custom vascularised bone graft in a man","volume":"364","author":"Warnke","year":"2004","journal-title":"Lancet"},{"key":"2021122217020526900_ref41","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1302\/0301-620X.90B9.20425","article-title":"Acetabular bone reconstruction in revision arthroplasty: A comparison of freeze-dried, irradiated and chemically-treated allograft vitalised with autologous marrow versus frozen non-irradiated allograft","volume":"90","author":"Ochs","year":"2008","journal-title":"J Bone Joint Surg Br"},{"key":"2021122217020526900_ref42","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.4081\/or.2009.e32","article-title":"Safety of autologous bone marrow aspiration concentrate transplantation: Initial experiences in 101 patients","volume":"1","author":"Hendrich","year":"2009","journal-title":"Orthop Rev (Pavia)"},{"key":"2021122217020526900_ref43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jor.21230","article-title":"Bridging the gap: Bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects","volume":"29","author":"J\u00e4ger","year":"2011","journal-title":"J Orthop Res"},{"key":"2021122217020526900_ref44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM200102013440516","article-title":"Repair of large bone defects with the use of autologous bone marrow stromal cells","volume":"344","author":"Quarto","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122217020526900_ref45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/BPO.0b013e318093f523","article-title":"Distraction osteogenesis of the lower extremity in patients with achondroplasia\/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma","volume":"27","author":"Kitoh","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"2021122217020526900_ref46","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bone.2006.09.019","article-title":"Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones","volume":"40","author":"Kitoh","year":"2007","journal-title":"Bone"},{"key":"2021122217020526900_ref47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BLO.0b013e3181591c92","article-title":"Osteonecrosis of the hip: Novel approaches to evaluation and treatment","volume":"465","author":"Petrigliano","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"2021122217020526900_ref48","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/00004623-200406000-00006","article-title":"Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study","volume":"86-A","author":"Gangji","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref49","first-page":"581","article-title":"Biopsy-forage in the treatment of primary femoro-capital osteonecrosis","volume":"79","author":"Ficat","year":"1971","journal-title":"Presse Med"},{"key":"2021122217020526900_ref50","first-page":"583","article-title":"Pathogenetic considerations in ischemic necrosis of bone","volume":"24","author":"Hungerford","year":"1981","journal-title":"Can J Surg"},{"key":"2021122217020526900_ref51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1302\/0301-620X.72B6.2246284","article-title":"Intra-osseous pressure and oxygen tension in avascular necrosis and osteoarthritis of the hip","volume":"72","author":"Kiaer","year":"1990","journal-title":"J Bone Joint Surg Br"},{"issue":"suppl 1","key":"2021122217020526900_ref52","first-page":"106","article-title":"Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique","volume":"87","author":"Gangji","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1302\/0301-620X.87B7.16289","article-title":"The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone","volume":"87","author":"Hernigou","year":"2005","journal-title":"J Bone Joint Surg Br"},{"key":"2021122217020526900_ref54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1525-1594.2006.00333.x","article-title":"Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: Transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula","volume":"30","author":"Kawate","year":"2006","journal-title":"Artif Organs"},{"key":"2021122217020526900_ref55","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2106\/JBJS.G.00620","article-title":"A randomized clinical trial comparing intralesional bone marrow and steroid injections for simple bone cysts","volume":"90","author":"Wright","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3113\/FAI.2008.0164","article-title":"A study of 23 unicameral bone cysts of the calcaneus: Open chip allogeneic bone graft versus percutaneous injection of bone powder with autogenous bone marrow","volume":"29","author":"Park","year":"2008","journal-title":"Foot Ankle Int"},{"key":"2021122217020526900_ref57","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00264-008-0619-7","article-title":"Efficacy of aspiration and autogenous bone marrow injection in the treatment of simple bone cysts","volume":"33","author":"Zamzam","year":"2009","journal-title":"Int Orthop"},{"key":"2021122217020526900_ref58","first-page":"105","article-title":"Percutaneous autologous bone marrow grafting for simple bone cysts","volume":"58","author":"K\u00f6se","year":"1999","journal-title":"Bull Hosp Jt Dis"},{"key":"2021122217020526900_ref59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1302\/0301-620X.78B6.0780934","article-title":"Simple bone cysts treated by percutaneous autologous marrow grafting. A preliminary report","volume":"78","author":"Lokiec","year":"1996","journal-title":"J Bone Joint Surg Br"},{"key":"2021122217020526900_ref60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157488809787169039","article-title":"Bone marrow concentrate: A novel strategy for bone defect treatment","volume":"4","author":"J\u00e4ger","year":"2009","journal-title":"Curr Stem Cell Res Ther"},{"key":"2021122217020526900_ref61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2010.12.002","article-title":"Biomolecular strategies of bone augmentation in spinal surgery","volume":"17","author":"Pneumaticos","year":"2011","journal-title":"Trends Mol Med"},{"key":"2021122217020526900_ref62","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1097\/01.brs.0000232028.97590.12","article-title":"Healos and bone marrow aspirate used for lumbar spine fusion: A case controlled study comparing healos with autograft","volume":"31","author":"Neen","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"key":"2021122217020526900_ref63","first-page":"493","article-title":"Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material","volume":"46","author":"Zhang","year":"2008","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"suppl","key":"2021122217020526900_ref64","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/00003086-200010001-00014","article-title":"Osteoinductive applications of regional gene therapy: Ex vivo gene transfer","volume":"379","author":"Oakes","year":"2000","journal-title":"Clin Orthop Relat Res"},{"key":"2021122217020526900_ref65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/mthe.2000.0663","article-title":"Gene transfer approaches to the healing of bone and cartilage","volume":"6","author":"Lieberman","year":"2002","journal-title":"Mol Ther"},{"key":"2021122217020526900_ref66","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2106\/00004623-199907000-00002","article-title":"The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats","volume":"81","author":"Lieberman","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref67","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.gt.3302195","article-title":"Regional gene therapy to enhance bone repair","volume":"11","author":"Baltzer","year":"2004","journal-title":"Gene Ther"},{"key":"2021122217020526900_ref68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1302\/0301-620X.89B1.18350","article-title":"Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats","volume":"89","author":"Tang","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"2021122217020526900_ref69","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM199410063311401","article-title":"Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation","volume":"331","author":"Brittberg","year":"1994","journal-title":"N Engl J Med"},{"key":"2021122217020526900_ref70","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-2004-832353","article-title":"Indications and implementation of recommendations of the working group \u201cTissue Regeneration and Tissue Substitutes\u201d for autologous chondrocyte transplantation (ACT)","volume":"142","author":"Behrens","year":"2004","journal-title":"Z Orthop Ihre Grenzgeb"},{"issue":"suppl 2","key":"2021122217020526900_ref71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2106\/00004623-200300002-00003","article-title":"Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: Results at two to ten years","volume":"85-A","author":"Peterson","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2106\/00004623-200302000-00001","article-title":"Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial","volume":"85-A","author":"Horas","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"2021122217020526900_ref73","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.joca.2011.02.010","article-title":"Failures, re-operations, and complications after autologous chondrocyte implantation\u2014a systematic review","volume":"19","author":"Harris","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"2021122217020526900_ref74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0030-1270894","article-title":"Factors that influence clinical outcome following autologous chondrocyte implantation for cartilage defects of the knee [in German]","volume":"150","author":"Niemeyer","year":"2012","journal-title":"Z Orthop Unfall"},{"key":"2021122217020526900_ref75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00167-008-0663-2","article-title":"Clinical application of scaffolds for cartilage tissue engineering","volume":"17","author":"Iwasa","year":"2009","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2021122217020526900_ref76","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3727\/000000004783983747","article-title":"Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports","volume":"13","author":"Wakitani","year":"2004","journal-title":"Cell Transplant"},{"key":"2021122217020526900_ref77","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/term.8","article-title":"Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: Three case reports involving nine defects in five knees","volume":"1","author":"Wakitani","year":"2007","journal-title":"J Tissue Eng Regen Med"},{"key":"2021122217020526900_ref78","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.joca.2006.08.008","article-title":"Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells","volume":"15","author":"Kuroda","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"2021122217020526900_ref79","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0363546509359067","article-title":"Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: An observational cohort study","volume":"38","author":"Nejadnik","year":"2010","journal-title":"Am J Sports Med"},{"key":"2021122217020526900_ref80","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1002\/art.11365","article-title":"Stem cell therapy in a caprine model of osteoarthritis","volume":"48","author":"Murphy","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021122217020526900_ref81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157488810790442796","article-title":"Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique","volume":"5","author":"Centeno","year":"2010","journal-title":"Curr Stem Cell Res Ther"},{"key":"2021122217020526900_ref82","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1756-185X.2011.01599.x","article-title":"Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients","volume":"14","author":"Davatchi","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"2021122217020526900_ref83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.revmed.2008.08.019","article-title":"Mesenchymal stem cells and immunomodulation: Toward new immunosuppressive strategies for the treatment of autoimmune diseases?","volume":"30","author":"Larghero","year":"2009","journal-title":"Rev Med Interne"},{"key":"2021122217020526900_ref84","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00393-008-0386-2","article-title":"Current value of stem-cell transplantation in autoimmune diseases","volume":"67","author":"K\u00f6tter","year":"2008","journal-title":"Z Rheumatol"},{"key":"2021122217020526900_ref85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","article-title":"Allogeneic mesenchymal stem cells transplantation in patients with refractory RA","volume":"31","author":"Liang","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2021122217020526900_ref86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar2563","article-title":"Gene therapy of the rheumatic diseases: 1998 to 2008","volume":"11","author":"Evans","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2021122217020526900_ref87","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1073\/pnas.0502854102","article-title":"Gene transfer to human joints: Progress toward a gene therapy of arthritis","volume":"102","author":"Evans","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122217020526900_ref88","first-page":"20","article-title":"Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs","volume":"2","author":"Kuo","year":"2010","journal-title":"Sports Med Arthrosc Rehabil Ther Technol"},{"key":"2021122217020526900_ref89","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bjsm.2006.029983","article-title":"Medial epicondylitis: Is ultrasound guided autologous blood injection an effective treatment?","volume":"40","author":"Suresh","year":"2006","journal-title":"Br J Sports Med"},{"key":"2021122217020526900_ref90","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bjsm.2008.056457","article-title":"Treatment of lateral epicondylitis using skin-derived tenocyte-like cells","volume":"43","author":"Connell","year":"2009","journal-title":"Br J Sports Med"},{"key":"2021122217020526900_ref91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00256-006-0081-9","article-title":"Ultrasound-guided autologous blood injection for tennis elbow","volume":"35","author":"Connell","year":"2006","journal-title":"Skeletal Radiol"},{"key":"2021122217020526900_ref92","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjsm.2006.034686","article-title":"Ultrasound guided dry needling and autologous blood injection for patellar tendinosis","volume":"41","author":"James","year":"2007","journal-title":"Br J Sports Med"},{"key":"2021122217020526900_ref93","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bjsm.2008.052761","article-title":"A systematic review of four injection therapies for lateral epicondylosis: Prolotherapy, polidocanol, whole blood and platelet-rich plasma","volume":"43","author":"Rabago","year":"2009","journal-title":"Br J Sports Med"},{"key":"2021122217020526900_ref94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0363546510387095","article-title":"Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy","volume":"39","author":"Clarke","year":"2011","journal-title":"Am J Sports Med"},{"key":"2021122217020526900_ref95","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1016\/j.biomaterials.2011.06.037","article-title":"The knee meniscus: Structure-function, pathophysiology, current repair techniques, and prospects for regeneration","volume":"32","author":"Makris","year":"2011","journal-title":"Biomaterials"},{"key":"2021122217020526900_ref96","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.addr.2010.09.013","article-title":"Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors","volume":"62","author":"Meyerrose","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"2021122217020526900_ref97","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1002\/term.424","article-title":"Tenogenic differentiation of stem cells for tendon repair-what is the current evidence?","volume":"5","author":"Lui","year":"2011","journal-title":"J Tissue Eng Regen Med"},{"key":"2021122217020526900_ref98","first-page":"12","article-title":"Functional tissue engineering of ligament healing","volume":"2","author":"Hsu","year":"2010","journal-title":"Sports Med Arthrosc Rehabil Ther Technol"},{"key":"2021122217020526900_ref99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csm.2008.08.009","article-title":"Stem cells for the treatment of skeletal muscle injury","volume":"28","author":"Quintero","year":"2009","journal-title":"Clin Sports Med"},{"key":"2021122217020526900_ref100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.20959","article-title":"From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells","volume":"211","author":"Giordano","year":"2007","journal-title":"J Cell Physiol"},{"key":"2021122217020526900_ref101","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/stem.459","article-title":"Concise review: Hitting the right spot with mesenchymal stromal cells","volume":"28","author":"Tolar","year":"2010","journal-title":"Stem Cells"},{"key":"2021122217020526900_ref102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1741-7015-9-52","article-title":"Clinical trials for stem cell therapies","volume":"9","author":"Trounson","year":"2011","journal-title":"BMC Med"},{"key":"2021122217020526900_ref103","first-page":"248","article-title":"Bone marrow and umbilical cord blood human mesenchymal stem cells: State of the art","volume":"3","author":"Malgieri","year":"2010","journal-title":"Int J Clin Exp Med"},{"key":"2021122217020526900_ref104","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2007.11.002","article-title":"Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment","volume":"36","author":"Marino","year":"2008","journal-title":"Exp Hematol"},{"key":"2021122217020526900_ref105","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122217020526900_ref106","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00167-010-1306-y","article-title":"Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use","volume":"19","author":"Kon","year":"2011","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2021122217020526900_ref107","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.injury.2010.11.016","article-title":"Bone morphogenetic proteins in orthopaedic trauma surgery","volume":"42","author":"Argintar","year":"2011","journal-title":"Injury"},{"key":"2021122217020526900_ref108","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrd3052","article-title":"Challenges with advanced therapy medicinal products and how to meet them","volume":"9","author":"Schneider","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2021122217020526900_ref109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00103-009-0991-5","article-title":"Regulatory requirements for clinical trial and marketing authorisation application for cell-based medicinal products","volume":"53","author":"Salmikangas","year":"2010","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2011-0036","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2011-0036","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/1\/3\/237\/41882567\/stcltm_1_3_237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/1\/3\/237\/41882567\/stcltm_1_3_237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T13:41:28Z","timestamp":1687441288000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/1\/3\/237-247\/6386200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,2,22]]},"published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2011-0036","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3,1]]},"published":{"date-parts":[[2012,2,22]]}}}